Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Angioimmunoblastic adenopathies]

G Mathé, J L Amiel, R Gérard-Marchant

La Nouvelle Presse Medicale

|June 12, 1976

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence.

Oncogene·2011

Same author

Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?

Endocrine-related cancer·2010

Same author

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis.

Medical oncology (Northwood, London, England)·2010

Same author

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

European journal of endocrinology·2010

Same author

Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2010

Same author

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

The Journal of clinical endocrinology and metabolism·2006

Same journal

[Forms of intra-erythrocytes asexual multiplication of P. falciparium. Production of monoclonal antibodies].

La Nouvelle presse medicale·2016

Same journal

[Cutaneous systemic angiitis in hairy cell leukemia].

La Nouvelle presse medicale·1982

Same journal

[Isolated late epilepsy as manifestation of glioblastoma. True negative tests with the scanner].

La Nouvelle presse medicale·1982

Same journal

[Non-specific benign ulcer of the colon. Arguments favoring its ischemic origin].

La Nouvelle presse medicale·1982

Same journal

[Relation between psychological stress and obstetrical complications. Preliminary data].

La Nouvelle presse medicale·1982

Same journal

[Significance of a "flat" curve of oral hyperglycemia. Comparison with a test meal].

La Nouvelle presse medicale·1982

See all related articles

Angio-lymphoblastic lymphadenopathies, a rare hematologic disorder, present with enlarged lymph nodes and spleen. Early stages are non-malignant and respond to corticosteroid therapy, though later sarcomatous transformation is possible.

Area of Science:

Hematology
Oncology
Pathology

Background:

Angio-lymphoblastic lymphadenopathies (AL L) represent a distinct hematological condition.
Characterized by a specific histological triad: vascular neogenesis, polymorphic cellular proliferation (often immunoblastic), and acidophilic protein deposits.

Observation:

Patients typically present with widespread lymphadenopathy and hepatosplenomegaly.
Laboratory findings often include polyclonal dysproteinemia.

Findings:

The disorder is not typically malignant in its initial phases.
Early-stage AL L demonstrates sensitivity to corticosteroid treatment.

Implications:

Early diagnosis and treatment with corticosteroids can be effective.

Related Experiment Videos

Awareness of potential secondary sarcomatous transformation is crucial for long-term patient management.